{"id":"NCT00340379","sponsor":"Duke University","briefTitle":"Ziprasidone vs. Sertraline/Haloperidol in Psychotic Depression","officialTitle":"A Comparison of Two Different Treatments for Major Depression With Psychotic Features: Ziprasidone vs. Combined Sertraline and Haloperidol","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2003-04","primaryCompletion":"2005-08","completion":"2005-08","firstPosted":"2006-06-21","resultsPosted":"2013-06-04","lastUpdate":"2014-08-19"},"enrollment":72,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Affective Disorders"],"interventions":[{"type":"DRUG","name":"Ziprasidone","otherNames":["Geodon"]},{"type":"DRUG","name":"Sertraline","otherNames":["Zoloft"]},{"type":"DRUG","name":"Haloperidol","otherNames":["Haldol"]}],"arms":[{"label":"Ziprasidone","type":"ACTIVE_COMPARATOR"},{"label":"Sertraline/Haloperidol","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to compare ziprasidone (Geodon) monotherapy for the treatment of psychotic major depression (PMD)with an antidepressant/antipsychotic combined therapy.","primaryOutcome":{"measure":"21 Item Hamilton Depression Rating Scale","timeFrame":"12 week","effectByArm":[{"arm":"Ziprasidone","deltaMin":13.6,"sd":8.3},{"arm":"Sertraline/Haloperidol","deltaMin":11,"sd":7.7}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":21},"locations":{"siteCount":3,"countries":["United States","Egypt","India"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":35},"commonTop":["Extrapyramidal symptoms","Akathisia","Tremors","Gastritis","Rigidity"]}}